Black Rose Industries Ltd Q4 FY25 Earnings Analysis
Published 25 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹588 Cr
Price
₹103
Market Cap
₹588 Cr
P/E Ratio
20.5
Earnings Summary
Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume. The company has exceeded standalone figures of FY22 in FY24-25, indicating positive volume growth.
📊 Revenue & Sales Performance
- →Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume.
- →Raw material prices have stabilized, aiding better price realization.
- →New products like acrylamide solid and N-methylol acrylamide (NMA) are steadily gaining market acceptance.
- →Capacity utilization for key products is improving, contributing to better margins and volume growth.
- →Export markets, especially in the U.S., may improve once tariff uncertainties clear.
- →Company is optimistic about enhancing market share and profitability through new product launches and expanded distribution.
- →Ongoing R&D and manufacturing initiatives (e.g., polyacrylamide solid) expected to positively impact growth.
- →The outlook remains positive both for the Indian chemical industry and the company’s long-term performance.
- →Sales growth driven by both domestic demand recovery and export expansion opportunities.
📈 Profitability & Margins
- →The company has exceeded standalone figures of FY22 in FY24-25, indicating positive volume growth.
- →Raw material prices have stabilized, aiding stable pricing and improved profitability.
- →New products like acrylamide solid and NMA are steadily gaining market acceptance, improving capacity utilization and margins.
- →Operational efficiencies such as renewable energy use and agro-based fuels are enhancing margins.
- →The addition of manufacturing products and new R&D initiatives are expected to strengthen the product pipeline.
- →The outlook for both the Indian chemical industry and the company is optimistic, with expectations of year-on-year performance improvement.
- →Price realizations are currently stable, though subject to market volatility.
- →The company emphasizes fair pricing policies, aiming for long-term customer relationships and profitability.
- →CAPEX investments (₹60-100 crores for PAM solid and ~₹50 crores for other projects) are planned to support growth.
🏗️ Capital Expenditure Plans
- →Polyacrylamide (PAM) solid project is progressing on schedule; commercial production expected by end of the current fiscal or start of next.
- →CAPEX for PAM solid estimated between ₹60 to ₹100 crores.
- →Additional upcoming projects include an amine manufacturing facility, with a feasibility study underway in collaboration with Koei Chemicals (Japan).
- →Total CAPEX for amine and other projects estimated around ₹50 crores.
- →Land registration for new parcels is near completion to create a land bank for future projects.
- →EC approval for the mines project at Jhagadia site is expected soon.
- →The pilot plant for PAM solid is near completion, with commercial plant expected to be ready by the fiscal year-end or next year’s first quarter.
- →Funding options for CAPEX include internal accruals, debt, or fresh equity; final decisions pending based on situation.
💰 Fundraising & Capital Structure
- →The company has not finalized any decision regarding fundraising for upcoming CAPEX projects.
- →Total CAPEX for the polyacrylamide solid project is estimated between INR 60 to 100 crores.
- →Additional projects, including the amine project and land acquisition, may together require around INR 50 crores.
- →The company is evaluating all funding options: internal accruals, debt, or fresh equity.
- →A definitive decision on the mode of fund sourcing will be taken once project modalities and detailed requirements are finalized.
- →Management has kept all options open and will share updates at the appropriate time.
📋 Order Book & Pipeline
The transcript provided on page 15 does not explicitly mention the current or expected order book or pending orders for Black Rose Industries Limited. However, relevant points indicating positive business outlook and growth are:
- The standalone business has exceeded FY22 figures in total volume.
- The company is focusing on maximizing market share, outreach, sales, and profitability.
- Outlook remains positive for the Indian chemical industry and the company.
- New manufacturing products and R&D initiatives are expected to augment the product pipeline and improve year-on-year performance.
- The company is proactively diversifying market outreach and adding new products.
- Stable distribution business and steady local sales with new customer additions hint at a steady flow of orders.
Specific quantitative details on order book or pending orders were not disclosed in the discussion available on page 15.
Key Metrics
Frequently Asked Questions
What were Black Rose Industries Ltd Q4 FY25 results?
Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume. The company has exceeded standalone figures of FY22 in FY24-25, indicating positive volume growth.
What is Black Rose Industries Ltd share price analysis?
Black Rose Industries Ltd currently shows a neutral. The stock trades at a P/E of 20.5 with a market cap of ₹588 Cr. Investors should review the full earnings analysis for detailed insights.
Is Black Rose Industries Ltd planning capital expenditure?
Polyacrylamide (PAM) solid project is progressing on schedule; commercial production expected by end of the current fiscal or start of next.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.